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Abstract: Background: The oral diacetylmorphine (DAM) prescription in tablet form in the Swiss heroin-
assisted treatment (sHAT) was regularly approved after positive experiences with galenic forms of DAM
in single patient cases already in the middle of the 1990ties und after a thorough scientific evaluation
study that resulted in high retention rates and comparatively low side effects in 2010. Aims: The present
report aims at the summary of the pharmacologic characteristics of oral DAM, the analysis of the variation
of oral DAM prescriptions in the sHAT in time and the description of practice experiences of the oral
DAM prescription. Results: The percent of exclusively intravenous DAM prescribed patients decrease
from 59.0% to 26.6% between 1999 and 2012. The oral DAM prescription (exclusively or in combination
with otherwise dispensed DAM) doubled since 1999 (1999: 10.6%, 2012: 23.8%). Similarly, did the
exclusively oral dispensary (2000: 7.1%, 2012: 13.3%). These trends are predominantly supported by
the manufactures´ selling numbers of distributed immediate release DAM to the sHAT dispensary sites.
Compared to the intravenous DAM, the oral DAM form is appropriate particularly for the harm reduced
application in case of bad vein conditions due the omission of infection risks, in the existence of respiratory
reductions (e.g. as a result of COPD) or as an alternative to the intramuscular application. Moreover,
oral DAM possesses benefits compared to other opioids with undesirable side effects (there is no QTc-
time-prolongation under the influence of DAM) or reduces sHAT dispensary site contacts in the presence
of limited physical mobility. Exactly polymorbid and older sHAT patients can profit of the oral DAM
prescription. Conclusions: The oral DAM application doubled in the sHAT in the investigated time frame
and will presumably reach the one of exclusively parenteral application. The oral DAM prescription could
improve the sHAT service by the omission or reduction of various complications that can occur during
the intravenous DAM dispensary.
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